The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Clinical trial NCT04928066 · COMPLETED

Trial details

NCT number: NCT04928066
Sponsor: Qilu Hospital of Shandong University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2020-03-01
Primary completion: 2023-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.